{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T17:45:59Z","timestamp":1791999959614,"version":"4.4.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","rbmojournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Reproductive BioMedicine Online"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.rbmo.2022.10.006","type":"journal-article","created":{"date-parts":[[2022,10,17]],"date-time":"2022-10-17T08:04:04Z","timestamp":1665993844000},"page":"511-518","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Comparison of recombinant human FSH biosimilar QL1012 with Gonal-f\u00ae for ovarian stimulation: a phase-three trial"],"prefix":"10.1016","volume":"46","author":[{"given":"Linli","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jieqiang","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianhong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiujuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dingfei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanhua","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohui","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingpu","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rbmo.2022.10.006_bib0001","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ejogrb.2019.07.032","article-title":"A multicenter, randomized, phase III study comparing the efficacy and safety of follitropin alpha biosimilar and the original follitropin alpha","volume":"241","author":"Barakhoeva","year":"2019","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"10.1016\/j.rbmo.2022.10.006_bib0002","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1093\/humrep\/12.10.2133","article-title":"'Recombinant human follicle stimulating hormone (r-hFSH; Gonal-F) versus highly purified urinary FSH (Metrodin HP): results of a randomized comparative study in women undergoing assisted reproductive techniques'","volume":"12","author":"Bergh","year":"1997","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.rbmo.2022.10.006_bib0003","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/jama.2021.4788","article-title":"Diagnosis and Management of Infertility: A Review","volume":"326","author":"Carson","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.rbmo.2022.10.006_bib0004","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1001\/jama.2015.6170","article-title":"Competition in the Age of Biosimilars","volume":"314","author":"Chandra","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.rbmo.2022.10.006_bib0005","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1097\/AOG.0000000000004658","article-title":"Effects of the Zishen Yutai Pill Compared With Placebo on Live Births Among Women in a Fresh Embryo Transfer Cycle: A Randomized Controlled Trial","volume":"139","author":"Chen","year":"2022","journal-title":"Obstetrics and Gynecology"},{"key":"10.1016\/j.rbmo.2022.10.006_bib0006","series-title":"Guideline on non-clinical and clinical development of similar biological medicinal products containing recombinant human follicle stimulating hormone (r-hFSH)","year":"2011"},{"key":"10.1016\/j.rbmo.2022.10.006_bib0007","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1093\/humupd\/8.6.559","article-title":"Epidemiology and prevention of ovarian hyperstimulation syndrome (OHSS): a review","volume":"8","author":"Delvigne","year":"2002","journal-title":"Human Reproduction Update"},{"key":"10.1016\/j.rbmo.2022.10.006_bib0008","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1093\/humupd\/4.6.862","article-title":"Recombinant follicle stimulating hormone: development of the first biotechnology product for the treatment of infertility","volume":"4","year":"1998","journal-title":"Hum. Reprod. Update"},{"key":"10.1016\/j.rbmo.2022.10.006_bib0009","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1152\/physrev.00023.2015","article-title":"Physiological Aspects of Female Fertility: Role of the Environment, Modern Lifestyle, and Genetics","volume":"96","author":"Hart","year":"2016","journal-title":"Physiological reviews"},{"key":"10.1016\/j.rbmo.2022.10.006_bib0010","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S1472-6483(10)62188-8","article-title":"Recombinant human follicle-stimulating hormone: a scientific step to clinical improvement","volume":"2","author":"Hugues","year":"2001","journal-title":"Reprod. Biomed. Online"},{"key":"10.1016\/j.rbmo.2022.10.006_bib0011","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1093\/humrep\/deh473","article-title":"Association of estradiol levels on the day of hCG administration and pregnancy achievement in IVF: a systematic review","volume":"19","author":"Kosmas","year":"2004","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.rbmo.2022.10.006_bib0012","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.1093\/humrep\/dep290","article-title":"Does the estradiol level on the day of human chorionic gonadotrophin administration have an impact on pregnancy rates in patients treated with rec-FSH\/GnRH antagonist?","volume":"24","author":"Kyrou","year":"2009","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.rbmo.2022.10.006_bib0013","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s40618-014-0204-4","article-title":"Human recombinant follicle stimulating hormone (rFSH) compared to urinary human menopausal gonadotropin (HMG) for ovarian stimulation in assisted reproduction: a literature review and cost evaluation","volume":"38","author":"Levi Setti","year":"2015","journal-title":"J. Endocrinol. Invest."},{"key":"10.1016\/j.rbmo.2022.10.006_bib0014","first-page":"139","article-title":"[The effect of serum estradiol levels on the outcome of controlled ovarian hyperstimulation and pregnancy]","volume":"21","author":"Li","year":"2013","journal-title":"Chinese Journal of Birth Health & Heredity"},{"key":"10.1016\/j.rbmo.2022.10.006_bib0015","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/j.fertnstert.2007.05.024","article-title":"Controlled ovarian hyperstimulation: are we monitoring the appropriate sex-steroid hormones?","volume":"89","author":"Orvieto","year":"2008","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.rbmo.2022.10.006_bib0016","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1093\/humrep\/17.11.2846","article-title":"Percentile curves of serum estradiol levels during controlled ovarian stimulation in 905 cycles stimulated with recombinant FSH show that high estradiol is not detrimental to IVF outcome","volume":"17","author":"Papageorgiou","year":"2002","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.rbmo.2022.10.006_bib0017","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.fertnstert.2009.01.109","volume":"93","author":"Quaas","year":"2010","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.rbmo.2022.10.006_bib0018","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S0015-0282(00)01735-0","article-title":"Value of the serum estradiol level on the day of human chorionic gonadotropin injection and on the day after in predicting the outcome in natural in vitro fertilization\/intracytoplasmic sperm injection cycles","volume":"75","author":"Reljic","year":"2001","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.rbmo.2022.10.006_bib0019","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.rbmo.2015.01.005","article-title":"A multi-centre phase 3 study comparing efficacy and safety of Bemfola(\u00ae) versus Gonal-f(\u00ae) in women undergoing ovarian stimulation for IVF","volume":"30","author":"Rettenbacher","year":"2015","journal-title":"Reproductive Biomedicine Online"},{"key":"10.1016\/j.rbmo.2022.10.006_bib0020","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1517\/14712598.2014.925872","article-title":"Biosimilar recombinant follicle stimulating hormones in infertility treatment","volume":"14","author":"Santi","year":"2014","journal-title":"Expert Opin. Biol. Ther."},{"key":"10.1016\/j.rbmo.2022.10.006_bib0021","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12958-015-0135-8","article-title":"Randomized, active-controlled, comparative phase 3 efficacy and safety equivalence trial of Ovaleap(R) (recombinant human follicle-stimulating hormone) in infertile women using assisted reproduction technology (ART)","volume":"14","author":"Strowitzki","year":"2016","journal-title":"Reprod. Biol. Endocrinol."},{"key":"10.1016\/j.rbmo.2022.10.006_bib0022","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.clinbiochem.2018.03.012","article-title":"Fertility and infertility: Definition and epidemiology","volume":"62","author":"Vander Borght","year":"2018","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.rbmo.2022.10.006_bib0023","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0015-0282(01)01973-2","volume":"76","author":"Westergaard","year":"2001","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.rbmo.2022.10.006_bib0024","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/1471-0528.14966","article-title":"Epidemiology of infertility in China: a population-based study","volume":"125","author":"Zhou","year":"2018","journal-title":"BJOG"}],"container-title":["Reproductive BioMedicine Online"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S147264832200760X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S147264832200760X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T08:25:24Z","timestamp":1761467124000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S147264832200760X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S147264832200760X"],"URL":"https:\/\/doi.org\/10.1016\/j.rbmo.2022.10.006","relation":{},"ISSN":["1472-6483"],"issn-type":[{"value":"1472-6483","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of recombinant human FSH biosimilar QL1012 with Gonal-f\u00ae for ovarian stimulation: a phase-three trial","name":"articletitle","label":"Article Title"},{"value":"Reproductive BioMedicine Online","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rbmo.2022.10.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Ltd on behalf of Reproductive Healthcare Ltd.","name":"copyright","label":"Copyright"}]}}